| Trial ID: | L6480 |
| Source ID: | NCT00941161
|
| Associated Drug: |
Metformin/Glimepiride Combination
|
| Title: |
Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: metformin/glimepiride combination|DRUG: metformin|DRUG: glimepiride
|
| Outcome Measures: |
Primary: fasting glucose, HbA1c, three months | Secondary: total cholesterol, C-LDL, C-HDL, triglycerides, VLDL, insulin, three months
|
| Sponsor/Collaborators: |
Sponsor: Laboratorios Silanes S.A. de C.V.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
28
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-02
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2010-05-18
|
| Locations: |
Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
|
| URL: |
https://clinicaltrials.gov/show/NCT00941161
|
